Dexmedetomidine for sedation in pediatric patients who received more than 20 sessions of radiation therapy: two cases report.
10.4097/kjae.2016.69.6.627
- Author:
Sun Key KIM
1
;
Myung Hee SONG
;
Il Jung LEE
;
Jae Hyuk LEE
;
In Cheol CHOI
Author Information
1. Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. icchoi@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Dexmedetomidine;
Pediatrics;
Radiotherapy
- MeSH:
Dexmedetomidine*;
Humans;
Pediatrics;
Radiotherapy;
Respiratory Insufficiency
- From:Korean Journal of Anesthesiology
2016;69(6):627-631
- CountryRepublic of Korea
- Language:English
-
Abstract:
Dexmedetomidine is a highly selective α2-adrenoceptor agonist that demonstrates anxiolytic and analgesic properties without inducing respiratory compromise, which makes it a suitable agent for procedural sedation and imaging studies. In our current case reports, intravenous dexmedetomidine infusion was used to provide sedation to 2 pediatric patients over more than 20 sessions of radiation therapy. On both occasions, dexmedetomidine provided adequate sedation without respiratory depression. However, the required dosage increased with repeated radiation therapy sessions.
